The role of soluble urokinase plasminogen activator receptor (SuPAR) as an indicator of the severity of acute pancreatitis
Author(s) -
Kadir Küçükceran,
Mehmet Ergın,
İbrahim Kılınç,
Adnan Karaibrahimoğlu,
Tamer Çolak,
Alpay Tuncar,
Zerrin Defne Dündar,
Sedat Koçak,
Sadık Girişgin,
Mehmet Gül,
Başar Cander
Publication year - 2018
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-1709-134
Subject(s) - supar , medicine , acute pancreatitis , pancreatitis , abdominal pain , prospective cohort study , urokinase receptor , urokinase , gastroenterology , intensive care medicine
Soluble urokinase plasminogen activator receptor (suPAR) has been reported to have a positive correlation with the activation degree of the immune system. This study’s aim is to investigate the efficiency of SuPAR serum levels in acute pancreatitis (AP) patients in determining the severity of disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom